These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 3524815)

  • 1. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity characteristics of reverse diol-epoxides of chrysene.
    Glatt H; Wameling C; Elsberg S; Thomas H; Marquardt H; Hewer A; Phillips DH; Oesch F; Seidel A
    Carcinogenesis; 1993 Jan; 14(1):11-9. PubMed ID: 8425257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
    Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
    Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
    Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of the optical isomers of the diastereomeric bay-region chrysene 1,3-diol-3,4-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Yagi H; Tada M; Vyas KP; Jerina DM; Conney AH
    Cancer Res; 1982 Aug; 42(8):2972-6. PubMed ID: 7046912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
    Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ
    Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenic potential of DNA adducts formed by diol-epoxides, triol-epoxides and the K-region epoxide of chrysene in mammalian cells.
    Phillips DH; Glatt HR; Seidel A; Bochnitschek W; Oesch F; Grover PL
    Carcinogenesis; 1986 Oct; 7(10):1739-43. PubMed ID: 3757175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-dihydrodiol epoxides in Salmonella typhimurium.
    Marshall MV; He ZM; Weyand EH; Rice JE; LaVoie EJ
    Environ Mol Mutagen; 1993; 22(1):34-45. PubMed ID: 8339723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Thakker DR; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1984 Jun; 44(6):2320-4. PubMed ID: 6372992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers.
    Melikian AA; Amin S; Huie K; Hecht SS; Harvey RG
    Cancer Res; 1988 Apr; 48(7):1781-7. PubMed ID: 3258179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
    Wood AW; Chang RL; Katz M; Conney AH; Jerina DM; Sikka HC; Levin W; Kumar S
    Cancer Res; 1989 Dec; 49(24 Pt 1):6981-4. PubMed ID: 2684405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple activation pathways of benzene leading to products with varying genotoxic characteristics.
    Glatt H; Padykula R; Berchtold GA; Ludewig G; Platt KL; Klein J; Oesch F
    Environ Health Perspect; 1989 Jul; 82():81-9. PubMed ID: 2676505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The formation of 9-hydroxychrysene-1,2-diol as an intermediate in the metabolic activation of chrysene.
    Hodgson RM; Seidel A; Bochnitschek W; Glatt HR; Oesch F; Grover PL
    Carcinogenesis; 1985 Jan; 6(1):135-9. PubMed ID: 3967334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats.
    Amin S; Lin JM; Krzeminski J; Boyiri T; Desai D; El-Bayoumy K
    Chem Res Toxicol; 2003 Feb; 16(2):227-31. PubMed ID: 12588194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.